| Years Ended December 31, | ||||||||
| 2017 | 2016 | |||||||
| Current | ||||||||
| Federal | $ | (109,214 | ) | $ | 329,732 | |||
| State | 13,194 | 55,836 | ||||||
| Net operating loss benefits | - | (343,588 | ) | |||||
| Deferred expense & change in valuation allowance | 914,130 | (4,213,570 | ) | |||||
| Net deferred tax asset revaluation adjustment | 1,150,318 | - | ||||||
| Provision (benefit) for income taxes | $ | 1,968,428 | $ | (4,171,590 | ) | |||
| Years Ended December 31, | ||||||||
| 2017 | 2016 | |||||||
| Federal tax at the statutory rate (34%) | $ | 791,867 | $ | 382,003 | ||||
| Benefit from permanent differences: | - | |||||||
| State income taxes, net of Federal tax benefit | 73,896 | (311,126 | ) | |||||
| Bank-owned life insurance | (74,019 | ) | (60,839 | ) | ||||
| Change in valuation allowance | (4,081,718 | ) | ||||||
| Net deferred tax asset revaluation adjustment | 1,150,318 | - | ||||||
| Other, net | 26,366 | (99,910 | ) | |||||
| Provision (benefit) for income taxes | $ | 1,968,428 | $ | (4,171,590 | ) | |||
| As of December 31, | ||||||||
| 2017 | 2016 | |||||||
| Deferred tax assets: | ||||||||
| Allowance for loan losses | $ | 720,047 | $ | 850,277 | ||||
| Unrealized losses on AFS securities | 77,931 | 170,450 | ||||||
| Board of Directors retirement plan | 232,748 | 316,823 | ||||||
| Tax credits | - | 91,688 | ||||||
| Other | 413,927 | 637,497 | ||||||
| Deferred compensation | 183,155 | 202,418 | ||||||
| Purchase accounting | 4,325 | 38,668 | ||||||
| Organizational costs | 93,404 | 169,772 | ||||||
| Net operating loss carryforwards | 1,014,199 | 2,456,793 | ||||||
| Total deferred tax assets | 2,739,736 | 4,934,386 | ||||||
| Deferred tax liabilities: | ||||||||
| FHLB stock dividends | (32,412 | ) | (27,820 | ) | ||||
| Depreciation and amortization | (336,613 | ) | (449,312 | ) | ||||
| Loan origination costs | (179,185 | ) | (140,237 | ) | ||||
| Total deferred tax liabilities | (548,210 | ) | (617,369.0 | ) | ||||
| Net deferred tax asset before valuation allowance | 2,191,526 | 4,317,017 | ||||||
| Valuation allowance: | ||||||||
| Beginning balance | - | (4,081,718 | ) | |||||
| Reversal of valuation allowance | - | 4,081,718 | ||||||
| Ending balance | - | - | ||||||
| Net deferred tax asset | $ | 2,191,526 | $ | 4,317,017 | ||||